Switzerland News
Most Popular Switzerland Story
Biogen inks $380M Alzheimer's deal with Neurimmune
Biogen Idec has struck a deal with Switzerland's Neurimmune Therapeutics to develop antibodies that attack the amyloid beta plaque fingered as a prime culprit in the neurodegenerative symptoms of Read more...
Latest Headlines
- September 14, 2009
- December 3, 2007
- November 20, 2007
- July 19, 2007
- July 16, 2007
- June 27, 2007
- June 26, 2007
- January 15, 2007
- January 3, 2007
- December 19, 2006
- November 7, 2006
- October 29, 2006
- October 23, 2006
- October 17, 2006
- August 22, 2006
- June 12, 2006
- May 1, 2006
- April 19, 2006
- March 12, 2006
- February 26, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
